These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37339401)

  • 1. Effects of Hypobaric Hypoxia on Coagulation in Healthy Subjects Exposed to 3,500 m Altitude.
    Kammerer T; Walzl A; Müller T; Groene P; Roveri G; Turner R; Roche J; Gatterer H; Siebenmann C; Schäfer ST
    High Alt Med Biol; 2023 Jun; 24(2):94-103. PubMed ID: 37339401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in body mass, appetite-related hormones, and appetite sensation in women during 4 days of hypobaric hypoxic exposure equivalent to 3,500-m altitude.
    Gatterer H; Roche J; Turner R; Vinetti G; Roveri G; Schlittler M; Kob M; Walzl A; Dal Cappello T; Debevec T; Siebenmann C
    J Appl Physiol (1985); 2023 Jan; 134(1):133-141. PubMed ID: 36476162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasma volume in male lowlanders during 4 days of exposure to hypobaric hypoxia equivalent to 3500 m altitude.
    Schlittler M; Gatterer H; Turner R; Regli IB; Woyke S; Strapazzon G; Rasmussen P; Kob M; Mueller T; Goetze JP; Maillard M; van Hall G; Feraille E; Siebenmann C
    J Physiol; 2021 Feb; 599(4):1083-1096. PubMed ID: 33124686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
    Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
    Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
    Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
    Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia briefly increases diuresis but reduces plasma volume by fluid redistribution in women.
    Roche J; Rasmussen P; Gatterer H; Roveri G; Turner R; van Hall G; Maillard M; Walzl A; Kob M; Strapazzon G; Goetze JP; Schäfer ST; Kammerer T; Nader E; Connes P; Robert M; Mueller T; Feraille E; Siebenmann C
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1068-H1079. PubMed ID: 36269645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women.
    Kristoffersen AH; Petersen PH; Bjørge L; Røraas T; Sandberg S
    Clin Chem Lab Med; 2018 Jul; 56(8):1297-1308. PubMed ID: 29648994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
    Bucciarelli P; Siboni SM; Stufano F; Biguzzi E; Canciani MT; Baronciani L; Pagliari MT; La Marca S; Mistretta C; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2015 Feb; 13(2):228-36. PubMed ID: 25425019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C; Miesbach W
    Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and shear stress in hypobaric hypoxia: time course and impact of plasma volume expansion in men.
    Tremblay JC; Ainslie PN; Turner R; Gatterer H; Schlittler M; Woyke S; Regli IB; Strapazzon G; Rauch S; Siebenmann C
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H980-H994. PubMed ID: 32886005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive.
    Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
    Thromb Haemost; 1999 Nov; 82(5):1456-61. PubMed ID: 10595638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
    Hillarp A; Friedman KD; Adcock-Funk D; Tiefenbacher S; Nichols WL; Chen D; Stadler M; Schwartz BA
    Haemophilia; 2015 Nov; 21(6):837-45. PubMed ID: 26172561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02/150).
    Hubbard AR; Heath AB
    J Thromb Haemost; 2004 Aug; 2(8):1380-4. PubMed ID: 15304044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
    Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
    J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using 7.0 T cardiac magnetic resonance to investigate the effect of estradiol on biventricular structure and function of ovariectomized rats exposed to chronic hypobaric hypoxia at high altitude.
    Zhang M; Zhu D; Wan Y; He B; Ma L; Li H; Wen X; Huang R; Chen B; Xiong L; Gao F
    Arch Biochem Biophys; 2022 Aug; 725():109294. PubMed ID: 35584725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Macitentan on the Vascular Tone and Recruitment of Finger Capillaries Under Hypobaric Hypoxia in High Altitude.
    Betge S; Drinda S; Neumann T; Bäz L; Pfeil A; Schulze C; Mrowka R; Jung C; Franz M
    High Alt Med Biol; 2020 Dec; 21(4):336-345. PubMed ID: 32758029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.